Medical/Pharmaceuticals
PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever
HONG KONG, Sept. 14, 2021 /PRNewswire/ -- Researchers at The Hong Kong Polytechnic University (PolyU) have developed a groundbreaking, imaging-guided nanoparticle photothermal treatment for osteoarthritis pain, utilising the concept of targeted cancer therapy but instead applied to the protein th...
2021-09-14 20:37
2449
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs
VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...
2021-09-14 15:00
6383
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002
SHANGHAI, Sept. 14, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-center, rand...
2021-09-14 11:43
4578
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
FREIBURG, Germany, Sept. 14, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-a...
2021-09-14 10:30
2224
CStone presents updated data from registrational clinical study of sugemalimab in patients with stage IV NSCLC in an oral presentation at IASLC 2021 WCLC
* Data with the longer follow-up showed that sugemalimab plus chemotherapy continued to demonstrate improvement in progression-free survival (PFS), after the primary efficacy endpoint was met at an interim PFS analysis last year * The updated data showed that the risk of disease progression or...
2021-09-14 08:30
5096
Global Investors Invest in Etana
JAKARTA, Indonesia, Sept. 14, 2021 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana)has secured a new round of investment led by Legend Capital along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). This round of funds will b...
2021-09-14 08:00
7517
Immune Checkpoint Inhibitors Convey Survival Benefit in Elderly patients with Stage IV Non-Small Cell Lung Cancer
DENVER, Sept. 14, 2021 /PRNewswire/ -- Because elderly patients with non-small cell lung cancer are likely to be excluded from clinical trials due to their lower functional capacity or comorbidities, survival benefit from immune checkpoint inhibitors (ICIs) remains unclear. In patients with non-s...
2021-09-13 23:00
2339
AnchorDx Develops New Liquid Biopsy Diagnostic Model for Early Detection of Breast Cancer
GUANGZHOU, China, Sept. 13, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, together with renowned experts from a top-tier hospital inChina, jointly published an article entitled"Circulating cell-free DNA-based methylation patterns for b...
2021-09-13 21:00
3458
Future Forum Announced the Winners of 2021 Future Science Prize: Kwok-Yung Yuen, Joseph Sriyal Malik Peiris, Jie Zhang, Simon Sze
BEIJING, Sept. 13, 2021 /PRNewswire/ -- Future Science Prize announced the winners of 2021 inBeijing on September 12th. Prof. Kwok-Yung Yuen and Prof. Joseph Sriyal Malik Peiris won the Prize in life sciences for their discoveries of SARS-CoV-1 as the causative agent for the global SARS outbreak ...
2021-09-13 19:03
2842
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...
2021-09-13 19:00
6839
FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke
STATE COLLEGE, Pa., Sept. 13, 2021 /PRNewswire/ -- * FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell's first-in-human clinical studies * Drug substance manufacturing will be carried out in...
2021-09-13 18:00
2331
Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors
HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a Phas...
2021-09-13 17:00
2129
Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets
SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited
2021-09-13 17:00
5519
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market
SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management ...
2021-09-10 18:30
5030
3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia
SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Shanghai-based biotechnology company, 3DMed Diagnostics, has donated anti-coronavirus medical appliances worth US$218,000 to Cambodia's Ministry of Health to support its campaign against COVID-19. A handover ceremony was held onFriday September 3 via video ...
2021-09-10 18:22
4077
Cytiva triples single-use consumables capacity in China
* Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. * Sustain and secure the supply chain for customers in China and the broader region. * With the use of Fortem™ film, Cytiva helps customers speed...
2021-09-10 16:33
3899
Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development
SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Winner Medical Co., Ltd. (300888.SZ), a leading manufacturer of high-quality medical and consumer products, celebrates its 30th anniversary this year alongside the release of its first annual corporate social responsibility report which highlights i...
2021-09-10 14:44
6678
Mindray Brings Increased Clinical Efficiency and Diagnostic Confidence to Medical Industry with New TE9 POC Ultrasound System
SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has today announced the launch of its latest Point-of-Care (POC) ultrasound system, the TE9, featuring a larger screen for enhanced viewing, intelligen...
2021-09-10 13:00
3458
DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants
PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...
2021-09-10 02:02
3010
Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices
Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...
2021-09-09 21:00
2338
Week's Top Stories
Most Reposted
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 286 media titles]
2026-05-26 10:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
[Picked up by 280 media titles]
2026-05-26 08:40
Consistently recognised: Infobip named a Leader in Gartner® Magic Quadrant™ for CPaaS again
[Picked up by 279 media titles]
2026-05-21 16:31
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
8351
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
8106
